Covidien Acquires BARRX Medical for $325,000,000
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=74a92680-14bd-4e88-88ef-9250c4e78ed7&Preview=1 -
Date
11/21/2011 -
Company Name
BARRX Medical -
Mailing Address
540 Oakmead Parkway Sunnyvale, CA 94085 -
Company Description
BARRX Medical, Inc. develops treatment solutions for Barrett’s esophagus, a precancerous condition of the lining of the esophagus (swallowing tube) caused by gastroesophageal reflux disease, or GERD. -
Website
http://www.barrx.com -
Transaction Type
M&A -
Transaction Amount
$325,000,000 -
Transaction Round
-
Proceeds Purposes
-
M&A Terms
Covidien will acquire all of the outstanding capital stock of BÂRRX, a private company, for approximately $325 million, with future earn out payments possible based on achievement of specific milestones.
